Table 3.
Correlationship of different cardiac proteins in diabetic versus non-diabetic heart failure
| Beclin1 | LV Mass | DF | CHF Peptide | Milrinone | Glucose | HgbA1C | mTOR | AMPK | |
|---|---|---|---|---|---|---|---|---|---|
| LC3B | |||||||||
| CC | -0.253 | -0.465 | -0.006 | -0.378 | -0.107 | -0.357 | 0.014 | 0.070 | -0.688 |
| P-value | 0.512 | 0.207 | 0.987 | 0.356 | 0.784 | 0.346 | 0.971 | 0.858 | 0.040 |
| Beclin1 | |||||||||
| CC | 0.066 | 0.124 | 0.200 | -0.313 | 0.638 | 0.554 | 0.351 | 0.482 | |
| P value | 0.865 | 0.750 | 0.635 | 0.412 | 0.064 | 0.122 | 0.354 | 0.189 | |
| LV Mass | |||||||||
| CC | -0.149 | -0.209 | -0.307 | 0.119 | 0.417 | 0.068 | 0.192 | ||
| P-value | 0.703 | 0.619 | 0.422 | 0.761 | 0.265 | 0.861 | 0.620 | ||
| DF | |||||||||
| CC | 0.101 | 0.158 | 0.647 | 0.512 | -0.058 | -0.294 | |||
| P-value | 0.811 | 0.685 | 0.059 | 0.159 | 0.882 | 0.443 | |||
| CHF peptide | |||||||||
| CC | -0.110 | 0.015 | 0.071 | 0.143 | 0.222 | ||||
| P-value | 0.796 | 0.971 | 0.868 | 0.735 | 0.597 | ||||
| Milrinone | |||||||||
| CC | 0.200 | -0.344 | -0.208 | -0.318 | |||||
| P-value | 0.606 | 0.364 | 0.592 | 0.405 | |||||
| Glucose | |||||||||
| CC | 0.619 | .348 | 0.054 | ||||||
| P-value | 0.075 | 0.359 | 0.890 | ||||||
| HgbA1C | |||||||||
| CC | 0.348 | -0.186 | |||||||
| P-value | 0.359 | 0.632 | |||||||
| mTOR | |||||||||
| CC | 0.223 | ||||||||
| P-value | 0.564 |
The number of samples are 9 for all except for CHF peptide, where the sample size is 8. CC = correlation co-efficient. LV mass = left ventricular mass, DF = diastolic function, CHF peptide = Congestive heart failure peptide (measurement of Brain Natriuretic Peptide), Milrinone = a drug for heart failure patients that improves heart rate and contractility, HgbA1C = Hemoglobin A1C, mTOR = mammalian target of rapamycin, AMPK = 5’Adenosine monophosphate (AMP) activated protein kinase.